MIRA INFORM REPORT

 

 

Report Date :

14.09.2013

 

IDENTIFICATION DETAILS

 

Name :

ABBOTT HEALTHCARE PRIVATE LIMITED (w.e.f. 08.05.2002)

 

 

Formerly Known As :

KNOLL INTERNATIONAL PRIVATE LIMITED

 

 

Registered Office :

Unit No.4, Corporate Park, Sion, Trombay Road, Chembur, Mumbai – 400071, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

01.01.1997

 

 

Com. Reg. No.:

11-104834

 

 

Capital Investment / Paid-up Capital :

Rs. 26.479 Millions

 

 

CIN No.:

[Company Identification No.]

U24200MH1997PTC104834

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMK06799C

 

 

PAN No.:

[Permanent Account No.]

AAACK3935D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Importer of Pharmaceutical Products.

 

 

No. of Employees :

2000 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (36)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 440000000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “Abbott Asia Holding Limited, UK”. It is an established company having a moderate track record.

 

The company has incurred huge loss from its operations during 2012.

 

However, trade relations are fair. Business is active. Payments are reported as slow but correct.

 

The company can be considered for business dealings with some caution. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Suhas

Designation :

Accounts Department

Contact No.:

91-22-66754132

Date :

13.09.2013

 

 

LOCATIONS

 

Registered Office :

Unit No.4, Corporate Park, Sion, Trombay Road, Chembur, Mumbai – 400071, Maharashtra, India

Tel. No.:

91-22-67978888

Fax No.:

91-22-67978733/ 67978727

E-Mail :

webmaster@abbott.co.in

Website :

http://www.abbott.co.in

http://www.abbott-diabetescare.com 

http://www.abbottep.in

http://www.truecare.in

 

 

Factory :

Located At

 

  • Baddi, Himachal Pradesh, India

 

 

Branch Office 1 :

Diabetes Care

12, Corporate Park, Sion-Trombay Road, Mumbai - 400 071, Maharashtra, India

Tel No. :

91-22-67978831

Fax. No. :

91-22-67978921

 

 

Branch Office 2 :

Diagnostics

 Office No. 201, Everest Grande, Opposite Ahura Centre, Mahakali Road, Andheri (East), Mumbai – 400069, Maharashtra, India

Tel No. :

91-22-66754132 / 33

Fax. No. :

91-22-66790468

 

 

Branch Office 3 :

Nutritional Products

11th Floor , Hall Mark Plaza, Near Gurunanak Hospital, Bandra (East), Mumbai – 400 051, Maharashtra, India

Tel No. :

91-22-67566000

Fax. No. :

91-22-67576060

 

 

Branch Office 4  :

Vascular

Office Floor, The Surya, New Friends Colony, New Delhi - 110025 India

Tel. No.:

91-22-40530100

Fax No.:

91-22-40530198/ 199

 

 

Branch Office 5 :

Healthcare Solutions

1st floor, D Mart Building, Goregaon - Mulund Link Road, Mumbai – 400080, MaharashtraIndia

Tel No. :

91-22-39536666

Fax. No. :

91-22-39536845

 

 

Branch Office 6 :

True Care

1st Floor, Su Motors Complex, Model Town, Bal Rajeshwar Marg, Mulund (West), Mumbai – 400080, Maharashtra, India

Tel No. :

91-22-30781000

Fax. No. :

91-22-30781080

 

 

Branch Office 7  :

Medical Optics

The Masterpiece Lavel – 5, Golf Course Road, Sector - 54, Gurgaon - 122002, Haryana, India

 

 

Corporate Office :

D’ Mart Building, Goregaon Mulund Link Road, Mulund – West, Mumbai – 400080, Maharashtra, India

Tel No. :

91-22-39536666

Fax. No. :

91-22-39536665

 

 

DIRECTORS

 

As on: 27.06.2013

 

Name :

Mr. Thomas Craig Freyman

Designation :

Director

Address :

912, Lake Street, Liberty Ville, Illinois-60048, USA

Date of Birth/Age :

08.09.1954

Date of Appointment :

02.05.2003

DIN No.:

00654517

 

 

Name :

Mr. Rajesh Upendra Pandya

Designation :

Director

Address :

B/23, 5th Floor, Sangam Apartment, 161 Versova Lane, Andheri (west), Mumbai – 400053, Maharashtra, India

Date of Birth/Age :

13.12.1963

Date of Appointment :

01.09.2005

DIN No.:

00096606

 

 

Name :

Mr. Sudarshan K Jain

Designation :

Director

Address :

Flat No. 101, 1st Floor, Jamunamahal Colony, Santacruz (East), Mumbai – 400055, Maharashtra, India

Date of Birth/Age :

06.06.1955

Qualification :

MBA

Date of Appointment :

25.07.2011

DIN No.:

00927487

 

 

Name :

Mr. Amal Satyawan Kelshikar

Designation :

Director

Address :

101, 10th floor, Dhanishta, Tarangan Complex Pokhran Road No.1, Near Samath Nagar, Thane (West), Thane – 400606, Maharashtra, India

Date of Birth/Age :

09.10.1967

Date of Appointment :

14.09.2012

DIN No.:

06378987

 

 

KEY EXECUTIVES

 

Name :

Mr. Kiran M Ravi

Designation :

Secretary

Address :

2B,92, Kalpataru, J.V. Link Road, Andheri (East), Mumbai – 400059, Maharashtra, India

Date of Birth/Age :

18.08.1977

Date of Appointment :

01.09.2009

PAN No.:

AFLPM7387Q

 

 

Name :

Mr. Suhas

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 27.06.2013

 

Names of Shareholders

 

No. of Shares

Abbott Asia Holding Limited, United Kingdom

 

2647928

Abbott Capital India Limited, Berkshire

 

2

Total

 

2647930

 

 

As on: 27.06.2013

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Importer of Pharmaceutical Products.

 

 

Imports :

 

Products :

Raw Materials

Countries :

Germany

 

 

Terms :

 

Selling :

L/C, Cash and Credit

 

 

Purchasing :

L/C, Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

End Users and OEM’s

 

 

No. of Employees :

2000 (Approximately)

 

 

Bankers :

Standard Chartered Bank, 90 M G Road, Fort, Mumbai - 400001, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.12.2012

As on

31.12.2011

Long-term borrowings

 

 

Long-term maturities of finance lease obligations

1.187

1.322

Total

1.187

1.322

 

 

 

Banking Relations :

--

 

 

Financial Institution :

BNP Paribas, French Bank Building, Fort, Mumbai – 400001, Maharashtra, India

 

 

Auditors :

 

Name :

Deloitte Hanskins and sells

Chartered Accountants

Address :

Maker Towers, "E" Cuffe Parade, Mumbai 400005, Maharashtra, India

Tel. No.:

91-22-66679000

Fax No.:

91-22-66679100

PAN No.:

AACFD4815A

 

 

Holding Company :

Abbott Asia Holdings Limited, UK

 

 

Ultimate Holding Company:

Abbott Laboratories, USA

 

 

Fellow Subsidiaries :

  • Abbott Australasia Pty. Limited, Australia
  • Abbott BV, Netherlands
  • Abbott Cardiovascular Systems, Inc, USA
  • Abbott Ireland
  • Abbott Diabetes Care Limited, UK
  • Abbott Diagnostics GmBH, Germany
  • Abbott Europe SA, Belgium
  • Abbott France S.A., France
  • Abbott GmBH and Company KG., Germany
  • Abbott India Limited, India
  • Abbott International LLC, USA
  • Abbott Korea Limited, Korea
  • Abbott Laboratories (M) Sdn. Bhd., Malaysia
  • Abbott Laboratories (Singapore) Pte Limited, Singapore
  • Abbott Laboratories International Company, USA
  • Abbott Laboratories Limited, Thailand
  • Abbott Laboratories Limited, United Kingdom
  • Abbott Laboratories Limited, Hongkong
  • Abbott Laboratories Poland, Poland
  • Abbott Laboratories SA, Dubai, UAE
  • Abbott Laboratories SA, USA
  • Abbott Laboratories Services Corp. Taiwan
  • Abbott Laboratories, Phillippines
  • Abbott Laboratries SA, Spain
  • Abbott Logistics BV, Netherlands
  • Abbott Manufacturing Singapore Pte Limited, Singapore
  • Abbott Medical Devices Trading (Shanghai) Company Limited, Shangai
  • Abbott Medical Laboratories Limited, Israel
  • Abbott Truecare Pharma Private Limited, India
  • Abbott Vascular Deutschland GMBH
  • Abbott Vascular Devices Holland BV, Netherlands
  • Abbott Vascular International BVBA, Belgium
  • Abbott Vascular Japan Company Limited, Japan
  • Abbott Vascular Knoll-Ravizza, Spain
  • Abbott Vascular, Ireland
  • Abbvie Laboratories (Singapore) Pte. Limited, Singapore
  • AMO India Private Limited, India
  • Solvay Pharma India Limited, India
  • Starlims (SEA) Pte Limited, Singapore
  • Starlims Asia Pacific Limited, Hongkong

 

 

CAPITAL STRUCTURE

 

As on 27.06.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

29700000

Equity Shares

Rs.10/- each

Rs.297.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2647930

Equity Shares

Rs.10/- each

Rs.26.479 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.12.2012

31.12.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

26.479

21.560

(b) Reserves & Surplus

 

110558.497

85279.186

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

18351.970

Total Shareholders’ Funds (1) + (2)

 

110584.976

103652.716

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

1.187

1.322

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

21962.618

42476.095

(d) long-term provisions

 

949.098

734.304

Total Non-current Liabilities (3)

 

22912.903

43211.721

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

3443.165

3103.910

(c) Other current liabilities

 

25452.166

22389.196

(d) Short-term provisions

 

598.179

529.151

Total Current Liabilities (4)

 

29493.510

26022.257

 

 

 

 

TOTAL

 

162991.389

172886.694

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

3038.818

2753.788

(ii) Intangible Assets

 

134901.210

152540.642

(iii) Capital work-in-progress

 

1741.171

458.370

(iv) Intangible assets under development

 

596.302

668.857

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

563.163

215.447

(e) Other Non-current assets

 

4.100

4.080

Total Non-Current Assets

 

140844.764

156641.184

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

4391.501

3552.286

(c) Trade receivables

 

2783.119

2443.993

(d) Cash and cash equivalents

 

11948.097

8963.964

(e) Short-term loans and advances

 

2782.516

1204.613

(f) Other current assets

 

241.392

80.654

Total Current Assets

 

22146.625

16245.510

 

 

 

 

TOTAL

 

162991.389

172886.694

 


 

SOURCES OF FUNDS

 

 

 

31.12.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

5.000

2] Share Application Money

 

 

107637.200

3] Reserves & Surplus

 

 

329.344

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

107971.544

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

0.000

DEFERRED TAX LIABILITIES

 

 

394.493

 

 

 

 

TOTAL

 

 

108366.037

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

173280.749

Capital work-in-progress

 

 

799.700

 

 

 

 

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 

2418.480

 

Sundry Debtors

 
 

2006.659

 

Cash & Bank Balances

 
 

5727.870

 

Other Current Assets

 
 

21.202

 

Loans & Advances

 
 

1073.970

Total Current Assets

 
 

11248.181

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
 

868.073

 

Other Current Liabilities

 
 

75045.049

 

Provisions

 
 

1049.471

Total Current Liabilities

 
 

76962.593

Net Current Assets

 
 

(65714.412)

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

108366.037

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.12.2012

31.12.2011

31.12.2010

 

SALES

 

 

 

 

 

Revenues

32058.812

27914.073

12134.402

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

 

Administrative Expenses

NA

NA

NA

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX

(15253.215)

(23078.016)

(310.258)

 

 

 

 

 

Less

TAX                                         

(3.593)

(407.343)

620.577

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

(15249.622)

(22670.673)

(930.835)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(22523.094)

147.579

1078.414

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(37772.716)

(22523.094)

147.579

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

4.386

10.522

NA

 

TOTAL EARNINGS

4.386

10.522

NA

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

1795.738

1127.639

NA

 

 

Spares

19.325

14.322

NA

 

 

Capital Goods

522.286

278.006

NA

 

 

Finished Goods

4903.792

3289.675

NA

 

TOTAL IMPORTS

7241.141

4709.642

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(5759.07)

(9521.49)

(1861.67)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.12.2012

31.12.2011

31.12.2010

Net Profit Margin

(PBT/Sales)

(%)

(47.58)

(82.68)

(2.56)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(9.49)

(13.44)

(0.17)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.14)

(0.22)

(0.00)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.75

0.62

0.15

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG-TERM DEBT: NOT AVAILABLE

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

NOTE :

 

Registered Office Address of the company has been shifted from Unit No.3 and 4 ,Corporate Park, Sion - Trombay Road, Chembur, Mumbai – 400071, Maharashtra, India to present w.e.f. 13.07.2009

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

 

Charge Holder

Address

Service Request Number (SRN)

1

10237333

01/09/2010

2,300,000,000.00

Standard Chartered Bank

90, M G Road,, Fort, Mumbai, Maharashtra - 400001, INDIA

A93238384

2

10240233

30/08/2010

1,600,000,000.00

BNP Paribas

French Bank Bldg, Homji Street, Fort, Mumbai, Maharashtra - 400001, INDIA

A94932324

 

 

FIXED ASSETS

 

  • Leasehold Improvement
  • Machinery and Equipments
  • Vehicles
  • Furniture, Fittings and Office Equipments
  • Goodwill

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.79

UK Pound

1

Rs.100.70

Euro

1

Rs.84.67

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

NTH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

4

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

36

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.